These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 16882104

  • 21. Lafutidine facilitates calcitonin gene-related peptide (CGRP) nerve-mediated vasodilation via vanilloid-1 receptors in rat mesenteric resistance arteries.
    Sugiyama T, Hatanaka Y, Iwatani Y, Jin X, Kawasaki H.
    J Pharmacol Sci; 2008 Mar; 106(3):505-11. PubMed ID: 18344609
    [Abstract] [Full Text] [Related]

  • 22. The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin.
    Rogers MJ, Holmfield JH, Primrose JN, Johnston D.
    Aliment Pharmacol Ther; 1990 Mar; 4 Suppl 1():65-74. PubMed ID: 1983347
    [Abstract] [Full Text] [Related]

  • 23. Cetraxate raises levels of calcitonin gene-related peptide and substance P in human plasma.
    Katagiri F, Sato Y, Itoh H, Takeyama M.
    J Pharm Pharmacol; 2004 Apr; 56(4):557-61. PubMed ID: 15099451
    [Abstract] [Full Text] [Related]

  • 24. Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability.
    Patil S, Talele GS.
    Drug Deliv; 2015 May; 22(3):312-9. PubMed ID: 24471787
    [Abstract] [Full Text] [Related]

  • 25. Clinical application of an enzyme immunoassay for cholecystokinin-like immunoreactive substance for determination of the human plasma levels: the effect of metoclopramide on gastrointestinal peptides and stress-related hormones.
    Katagiri F, Inoue S, Itoh H, Takeyama M.
    J Pept Sci; 2006 May; 12(5):311-20. PubMed ID: 16245263
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Afferent signalling from the acid-challenged rat stomach is inhibited and gastric acid elimination is enhanced by lafutidine.
    Edelsbrunner ME, Nakano M, Holzer P.
    BMC Gastroenterol; 2009 Jun 02; 9():40. PubMed ID: 19490646
    [Abstract] [Full Text] [Related]

  • 30. Characterization of metabolites of a novel histamine H(2)-receptor antagonist, lafutidine, in human liver microsomes by liquid chromatography coupled with ion trap mass spectrometry.
    Wang Y, Chen X, Li Q, Zhong D.
    Rapid Commun Mass Spectrom; 2008 Jun 02; 22(12):1843-52. PubMed ID: 18470870
    [Abstract] [Full Text] [Related]

  • 31. Calcitonin gene-related peptide levels are elevated in patients with sepsis.
    Joyce CD, Fiscus RR, Wang X, Dries DJ, Morris RC, Prinz RA.
    Surgery; 1990 Dec 02; 108(6):1097-101. PubMed ID: 2247835
    [Abstract] [Full Text] [Related]

  • 32. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health.
    Grudell AB, Camilleri M, Jensen KL, Foxx-Orenstein AE, Burton DD, Ryks MD, Baxter KL, Cox DS, Dukes GE, Kelleher DL, Zinsmeister AR.
    Am J Physiol Gastrointest Liver Physiol; 2008 May 02; 294(5):G1114-9. PubMed ID: 18372395
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetic Properties of Oral Lafutidine Tablets and the Effect of Food on its Pharmacokinetics in Healthy Chinese Subjects.
    Li S, Xu M, Li H, Du J, Li W.
    Adv Ther; 2016 Oct 02; 33(10):1704-1714. PubMed ID: 27444313
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hypotension- and endotoxin-induced alterations in calcitonin gene-related peptide: modulation by dexamethasone.
    Wang X, Han CD, Fiscus RR, Qi M, Jones SB.
    Circ Shock; 1991 Jun 02; 34(2):217-23. PubMed ID: 1934321
    [Abstract] [Full Text] [Related]

  • 36. Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values.
    Iida H, Inamori M, Nozaki Y, Endo H, Hosono K, Akiyama T, Sakamoto Y, Takahashi H, Koide T, Tokoro C, Abe Y, Nakajima A.
    BMC Gastroenterol; 2009 Jul 09; 9():52. PubMed ID: 19589146
    [Abstract] [Full Text] [Related]

  • 37. Comparative study of plasma gastrin levels in rats after two months of ebrotidine administration.
    Romero A, Gómez F, Villamayor F, Ballesta A, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr 09; 47(4A):524-7. PubMed ID: 9205757
    [Abstract] [Full Text] [Related]

  • 38. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA.
    Clin Ther; 2008 Oct 09; 30(10):1831-43. PubMed ID: 19014838
    [Abstract] [Full Text] [Related]

  • 39. Cardiopulmonary bypass influences the plasma levels of calcitonin gene-related peptides in dogs: effects of hemofiltration and hemodilution.
    Isaka M, Imamura M, Sakuma I, Makino Y, Shiiya N, Yasuda K.
    Res Vet Sci; 2007 Feb 09; 82(1):110-4. PubMed ID: 16839577
    [Abstract] [Full Text] [Related]

  • 40. Dual effect of lafutidine on the gut and liver.
    Kaneko H.
    J Gastroenterol Hepatol; 2003 Mar 09; 18(3):237-8. PubMed ID: 12603521
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.